Actinogen Medical Limited

ASX:ACW Stok Raporu

Piyasa değeri: AU$70.5m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Actinogen Medical Yönetim

Yönetim kriter kontrolleri 2/4

Actinogen Medical's CEO'su Steve Gourlay, Mar2021 tarihinde atandı, in görev süresi 3.58 yıldır. in toplam yıllık tazminatı A$ 754.11K olup, şirket hissesi ve opsiyonları dahil olmak üzere 54.7% maaş ve 45.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 3.56% ine doğrudan sahiptir ve bu hisseler A$ 2.51M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.7 yıl ve 6.8 yıldır.

Anahtar bilgiler

Steve Gourlay

İcra Kurulu Başkanı

AU$754.1k

Toplam tazminat

CEO maaş yüzdesi54.7%
CEO görev süresi3.6yrs
CEO sahipliği3.6%
Yönetim ortalama görev süresi2.7yrs
Yönetim Kurulu ortalama görev süresi6.8yrs

Son yönetim güncellemeleri

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Apr 30
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

CEO Tazminat Analizi

Steve Gourlay'un ücretlendirmesi Actinogen Medical'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$754kAU$412k

-AU$13m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$13m

Jun 30 2023AU$657kAU$396k

-AU$11m

Mar 31 2023n/an/a

-AU$11m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$10m

Jun 30 2022AU$955kAU$376k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$271kAU$112k

-AU$4m

Tazminat ve Piyasa: Steve 'nin toplam tazminatı ($USD 519.57K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 313.13K ).

Tazminat ve Kazançlar: Steve şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Steve Gourlay (65 yo)

3.6yrs

Görev süresi

AU$754,111

Tazminat

Dr. Steven G. Gourlay, also known as Steve, MBBS (M.D.), Ph D., FRACP, M.B.A., serves as Chief Executive Officer at Actinogen Medical Limited since March 15, 2021 and as its Managing Director and Director...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Steven Gourlay
MD, CEO & Director3.6yrsAU$754.11k3.56%
A$ 2.5m
William Souter
Chief Financial Officerless than a yearAU$476.62k0.015%
A$ 10.4k
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board1.7yrsAU$913.27kVeri yok
Michael Roberts
Head of Investor Relations & Corporate Communications3.4yrsVeri yokVeri yok
Paul Rolan
Head of Clinical Pharmacology & Lead Physician and Depression2.7yrsAU$191.66kVeri yok
Fujun Li
Head of Manufacturing1.2yrsVeri yokVeri yok
Peter Webse
Company Secretary11yrsVeri yokVeri yok

2.7yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim: ACW 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.7 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Steven Gourlay
MD, CEO & Director3.6yrsAU$754.11k3.56%
A$ 2.5m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board2.8yrsAU$913.27kVeri yok
George Morstyn
Independent Non-Executive Director6.8yrsAU$114.27k0.44%
A$ 311.3k
Geoffrey Edward Brooke
Independent Non-Executive Chairman7.6yrsAU$234.39k0.70%
A$ 490.2k
Colin Masters
Member of Xanamem Clinical Advisory Board9.6yrsVeri yokVeri yok
Jeffrey Cummings
Member of Xanamem Clinical Advisory Board9.6yrsVeri yokVeri yok
Malcolm McComas
Independent Non-Executive Director5.5yrsAU$114.27k0.26%
A$ 186.5k
John Harrison
Member of Depression & Cognition Clinical Advisory Board2.8yrsVeri yokVeri yok
Craig Ritchie
Chairman of Xanamem Clinical Advisory Board9.6yrsVeri yokVeri yok
Jonathan Seckl
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Brian Walker
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Scott Webster
Member of Scientific Advisory Boardno dataVeri yokVeri yok

6.8yrs

Ortalama Görev Süresi

71yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ACW 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).